Table 1 Baseline characteristics.

From: Association between diabetes status and subsequent onset of glaucoma in postmenopausal women

N

Diabetes status

No diabetes

Impaired fasting glucose

New onset diabetes

Diabetes treated with oral hypoglycemic medication

Diabetes treated with insulin

867,390

328,736

35,439

119,552

21,123

Demographics

Age

60.66 ± 8.20

61.75 ± 8.25

62.83 ± 8.52

64.80 ± 7.75

65.24 ± 7.75

Smoking

Non

835,933 (96.37)

315,689 (96.03)

33,759 (95.26)

114,637 (95.89)

20,200 (95.63)

Ex

8890 (1.02)

3697 (1.12)

390 (1.10)

1431 (1.20)

276 (1.31)

Current

22,567 (2.60)

9350 (2.84)

1290 (3.64)

3484 (2.91)

647 (3.06)

Alcohol drinking

No

757,370 (87.32)

281,904 (85.75)

30,436 (85.88)

109,844 (91.88)

19,899 (94.21)

Mild

106,102 (12.23)

44,430 (13.52)

4690 (13.23)

9264 (7.75)

1178 (5.58)

Heavy

3918 (0.45)

2402 (0.73)

313 (0.88)

444 (0.37)

46 (0.22)

Regular Exercise

161,459 (18.61)

59,471 (18.09)

6053 (17.08)

22,648 (18.94)

3705 (17.54)

Income (lowest quintile)

200,051 (23.06)

74,451 (22.65)

8369 (23.62)

25,618 (21.43)

4258 (20.16)

Past medical history

Diabetes mellitus

0 (0)

0 (0)

35,439 (100)

119,552 (100)

21,123 (100)

Hypertension

336,269 (38.77)

167,296 (50.89)

21,234 (59.92)

85,631 (71.63)

16,141 (76.41)

Dyslipidemia

248,890 (28.69)

126,491 (38.48)

15,711 (44.33)

64,910 (54.29)

12,662 (59.94)

Chronic kidney disease

85,653 (9.87)

41,059 (12.49)

5373 (15.16)

21,144 (17.69)

5677 (26.88)

Laboratory findings

Systolic blood pressure, mmHg

123.93 ± 15.90

127.62 ± 16.12

130.28 ± 16.73

129.77 ± 16.15

129.52 ± 16.85

Diastolic blood pressure, mmHg

76.21 ± 10.10

78.04 ± 10.18

79.16 ± 10.38

77.87 ± 10.04

77.02 ± 10.37

Fasting blood glucose, mg/dL

88.62 ± 7.25

107.84 ± 6.56

147.83 ± 33.30

133.88 ± 42.33

148.93 ± 63.20

Cholesterol, mg/dL

206.98 ± 41.99

214.58 ± 45.38

218.92 ± 48.19

199.36 ± 48.42

195.48 ± 52.1

Body mass index, kg/cm2

23.8 ± 2.99

24.52 ± 3.15

25.08 ± 3.36

25.19 ± 3.35

24.86 ± 3.42

Reproductive factors

Age at menarche, y

16.41 ± 1.84

16.48 ± 1.83

16.56 ± 1.82

16.58 ± 1.81

16.59 ± 1.80

− 11

8746 (1.01)

3037 (0.92)

286 (0.81)

917 (0.77)

160 (0.76)

12–15

452,384 (52.15)

166,555 (50.67)

17,314 (48.86)

57,589 (48.17)

10,007 (47.37)

16-

406,260 (46.84)

159,144 (48.41)

17,839 (50.34)

61,046 (51.06)

10,956 (51.87)

Age at menopause, y

49.98 ± 3.95

50.08 ± 4.02

50.06 ± 4.17

50.1 ± 4.32

49.9 ± 4.46

− 39

14,430 (1.66)

5352 (1.63)

675 (1.90)

2525 (2.11)

515 (2.44)

40–44

48,832 (5.63)

18,581 (5.65)

2148 (6.06)

7465 (6.24)

1472 (6.97)

45–49

239,985 (27.67)

88,770 (27.00)

9195 (25.95)

30,284 (25.33)

5466 (25.88)

50–54

477,880 (55.09)

179,398 (54.57)

19,271 (54.38)

63,299 (52.95)

10,918 (51.69)

55-

86,263 (9.95)

36,635 (11.14)

4150 (11.71)

15,979 (13.37)

2752 (13.03)

Total reproductive years

33.57 ± 4.33

33.6 ± 4.41

33.5 ± 4.57

33.52 ± 4.72

33.31 ± 4.83

− 29

116,954 (13.48)

45,177 (13.74)

5161 (14.56)

18,086 (15.13)

3458 (16.37)

30–34

364,967 (42.08)

136,751 (41.60)

14,731 (41.57)

48,688 (40.73)

8796 (41.64)

35–39

333,568 (38.46)

124,948 (38.01)

13,070 (36.88)

43,284 (36.21)

7224 (34.20)

40-

51,901 (5.98)

21,860 (6.65)

2477 (6.99)

9494 (7.94)

1645 (7.79)

Hormone replacement therapy

None

691,411 (79.71)

268,870 (81.79)

29,991 (84.63)

101,322 (84.75)

17,805 (84.29)

 < 2 years

83,868 (9.67)

28,849 (8.78)

2501 (7.06)

8101 (6.78)

1399 (6.62)

2–5 years

35,389 (4.08)

11,262 (3.43)

961 (2.71)

3063 (2.56)

543 (2.57)

 ≥ 5 years

27,363 (3.15)

7929 (2.41)

692 (1.95)

2666 (2.23)

501 (2.37)

Unknown

29,359 (3.38)

11,826 (3.60)

1294 (3.65)

4400 (3.68)

875 (4.14)

Parity

None

22,117 (2.55)

8122 (2.47)

817 (2.31)

2431 (2.03)

410 (1.94)

1

55,875 (6.44)

19,628 (5.97)

1969 (5.56)

5080 (4.25)

899 (4.26)

 ≥ 2

789,398 (91.01)

300,986 (91.56)

32,653 (92.14)

112,041 (93.72)

19,814 (93.80)

Breastfeeding

None

60,027 (6.92)

21,537 (6.55)

2140 (6.04)

6013 (5.03)

1045 (4.95)

 < 6 months

61,690 (7.11)

20,906 (6.36)

1830 (5.16)

5011 (4.19)

833 (3.94)

6 months-1 year

157,643 (18.17)

56,712 (17.25)

5560 (15.69)

16,664 (13.94)

2934 (13.89)

 ≥ 1 year

588,030 (67.79)

229,581 (69.84)

25,909 (73.11)

91,864 (76.84)

16,311 (77.22)

Oral contraceptive use

None

696,490 (80.30)

261,485 (79.54)

28,383 (80.09)

93,811 (78.47)

16,506 (78.14)

 < 1 year

78,350 (9.03)

30,324 (9.22)

3051 (8.61)

10,811 (9.04)

1831 (8.67)

 ≥ 1 year

50,104 (5.78)

20,468 (6.23)

2205 (6.22)

8828 (7.38)

1612 (7.63)

Unknown

42,446 (4.89)

16,459 (5.01)

1800 (5.08)

6102 (5.10)

1174 (5.56)

  1. All baseline characteristics are statistically significant at 0.001.